{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-086284","form_type":"8-K","ticker":"JANX","cik":"0001817713","company_name":"Janux Therapeutics, Inc.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.857571+00:00","generated_at":"2026-05-19T08:56:14.936462+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Janux Therapeutics shareholders elect three Class I directors, ratify EY","bullets":["David Campbell, Ron Barrett, and Winston Kung elected Class I directors with >42M votes each.","Ernst & Young ratified as auditor for FY2025: 56.15M for, 27K against.","Advisory vote on executive compensation approved: 53.2M for, 1.15M against.","Advisory vote favors 1-year frequency for future say-on-pay votes: 54.0M for 1 year.","59.2M shares outstanding, 56.2M present at meeting; broker non-votes of 1.87M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-086284","json":"https://secwatch.observer/filing/0000950170-25-086284.json","markdown":"https://secwatch.observer/filing/0000950170-25-086284.md","text":"https://secwatch.observer/filing/0000950170-25-086284.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817713/000095017025086284/0000950170-25-086284-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817713/000095017025086284/janx-20250611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T08:56:14.936462+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}